Mama-Match
NewSelf review
⛔ FDA warning letter #721472 (Feb. 2026), which names newself.com. Flat price at every dose: $99.97/mo semaglutide, $144.49/mo tirzepatide, three months upfront.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
Gentler first steps than NewSelf
Providers we'd send a friend to, with the ones we work with listed first — CoreAge Rx leads our ranking on the score. Some of these links earn MamaGLP a referral commission.
- Meet CoreAge RxCoreAge RxOur #1 pick
$99/mo semaglutide, $149/mo tirzepatide, one flat price with both medications in a single account — and an intake that walks you through it instead of cornering you with a quiz.
- Meet yourEra
From $99/mo semaglutide, $169/mo tirzepatide, physician-founded with cancel-anytime terms — the rates are a floor that only firms up after the eligibility check.
- Meet Willow
$299/mo semaglutide, $399/mo tirzepatide, both public before any questionnaire, with a name and a face on every prescribing doctor — 36 states only, and the cost climbs with your dose.
NewSelf at a glance
- Semaglutide
- $99.97/mo
- Tirzepatide
- $144.49/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored NewSelf
Each factor is judged from NewSelf's actual pricing, disclosures and support, then combined into the Mama-Match Score of 70/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
A reasonable intake, though a little more standard than hand-held.
Fair pricing once you get past any teaser rate or plan structure.
Little public detail about who oversees your care, and how.
Available in all 50 states, so where you live is not a barrier.
Support is thin once the prescription ships.
Canceling carries real friction — commitments, notice windows or non-refundable charges.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- Medium
$99.97 and $144.49, flat regardless of dose, across all fifty states. What constrains this isn't the price but the term: three months up front, with no real month-to-month option.
What to expect when you sign up
We walked NewSelf's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1Homepage lists a real flat price for both molecules directly ('As Low As $99.97' semaglutide, '$144.49' tirzepatide), no intake required to see the numbers
- 2States 'Access board-certified doctors in all 50 states' and 'Get 3 months upfront — no delays, no refill hassles'
- 3Publishes its own competitor comparison chart naming several rivals' pricing and membership fees
- 4Claims 'signup to treatment in as little as 4 days' and '1000+ physicians'
What we noticed
- Flat, dose-independent pricing is stated explicitly and repeatedly for both molecules — 'One Price. Any Dose. Others charge more for higher doses — we don't'
- Requires 3 months upfront, which is a real commitment even though the per-month price is flat
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- No named compounding pharmacy or medical director found anywhere on its site
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99.97 | Semaglutide+, all dosages same priceIncludes B12 and glycine additives. 'All dosages are the same price' — no escalation as dose increases. |
| Compounded tirzepatide | $144.49 | Tirzepatide+, all dosages same priceIncludes B6 and glycine additives. 'All dosages are the same price' — no escalation as dose increases. |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what NewSelf disclosed publicly at our last review and change often; confirm the current number on NewSelf's site.
What we like
- Explicitly flat, dose-independent pricing for both molecules — a real differentiator most competitors don't offer
- Nationwide (all 50 states)
- Fast: signup to treatment in as little as 4 days, per the site
- Publishes its own named competitor-comparison pricing chart
The caveats
- ⛔ FDA warning letter #721472, dated February 20, 2026, to NewSelf Limited dba NewSelf, for false or misleading claims and misbranding — the letter names its own site
- Requires 3 months upfront rather than a true month-to-month option
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- No named compounding pharmacy or medical director found anywhere on its site
- No brand-name (FDA-approved) option and no oral form
NewSelf for moms: our verdict
⛔ FDA warning letter #721472 (Feb. 2026), which names newself.com. Flat price at every dose: $99.97/mo semaglutide, $144.49/mo tirzepatide, three months upfront. It runs about $99.97/mo, flat across every dose — toward the affordable end of what we track.
We looked at NewSelf the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What NewSelf actually costs
- Compounded semaglutide — Semaglutide+, all dosages same price: $99.97/mo
- Compounded tirzepatide — Tirzepatide+, all dosages same price: $144.49/mo
That lands below the median ongoing price of about $175 across the providers we track for moms — a real cost advantage.
NewSelf prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.
That price covers the consult, the medication and shipping.
The medications NewSelf prescribes
NewSelf prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss results, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better fit. These are compounded formulas from a licensed pharmacy — the reason the price stays low — but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.
Where it operates. NewSelf lists its coverage as: All 50 states.
Where NewSelf fits — and where it doesn't — for moms
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- you may need to switch between semaglutide and tirzepatide as your body and your hormones change.
- uninterrupted nationwide access matters to you — a move for the family shouldn't interrupt your care.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
- you'd rather have a clinician talk the timing through with you, with the right timing around pregnancy and nursing in mind — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety and oversight
Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
A standing caution for moms: GLP-1 medications are not proven safe during pregnancy or breastfeeding, and every label advises against use. None of this changes that — plan the timing with your own healthcare provider.
The bottom line
NewSelf is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.
The bottom line
Best for: Moms who want a genuinely flat price that never climbs as their dose increases, and are comfortable prepaying 3 months.
Keep comparing NewSelf
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
NewSelf, answered
- How much does NewSelf cost?
- As of our last review, NewSelf's compounded pricing starts around $99.97/mo ($99.97/mo semaglutide, $144.49/mo tirzepatide). Confirm the current all-in price on NewSelf's site before you commit.
- Is NewSelf safe to use while breastfeeding?
- Here is the honest answer: no GLP-1 — compounded or brand-name — is established as safe during pregnancy or breastfeeding, and the labels advise against use; NewSelf is no exception. Plan any GLP-1 for after weaning, and talk the timing through with your own clinician.
- Does NewSelf offer both semaglutide and tirzepatide?
- Yes — NewSelf offers both. Tirzepatide's dual action is often preferred when insulin resistance is driving the weight, which matters with PCOS and after gestational diabetes.
- Where does NewSelf land in your ranking?
- NewSelf scores 70/100 on our Mama-Match Score (rank #41), which weights six things that matter to a first-timer. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Prices, states and verification reflect what NewSelf disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is gentle background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.